Breaking News- EECP for Long COVID treatment. Read Press Release
Long COVID describes signs and symptoms that continue or develop after four weeks of an acute COVID-19 infection. Common symptoms of Long COVID may include fatigue, chest pain, brain fog, headaches and difficulty breathing. These post-COVID conditions may also be known as long-haul COVID, post-acute COVID-19, long-term effects of COVID, or chronic COVID. An FDA approved treatment called Enhanced External Counter-pulsation (EECP®) has been used in medical settings for years with cardiology patients to treat similar symptoms like shortness of breath and chest pain. Flow Therapy is treating patients from several leading healthcare systems including patients with Long COVID in Texas, Arizona, and North Carolina, with significant results:
Juan Cabrera, M.D, at UT Southwestern Medical Center commented, “These findings are important, as over 50% of post-COVID patients suffer from lingering long-term symptoms. These statistically significant findings using validated clinical tools provide the first glimpse of hope as one potential treatment strategy for persistent symptoms after COVID.”
Sachin A. Shah, PharmD, chief scientific officer of Flow Therapy, the leading provider of EECP treatments explained “Patients with Long COVID need viable treatment options. The results we’re seeing, indicate that EECP® appears to be a powerful and effective solution for these patients and potentially the best thing available.”